GLYXAMBI

Trials studying GLYXAMBI

• phase2A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Diseasecompletedn=492
• phase3EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Diseaserecruitingn=11,800
• phase3A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)recruitingn=1,500
• phase2A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancerrecruitingn=1,132
• phase2Placebo-controlled, Proof-of-concept Study to Evaluate the Safety and Efficacy of Lanifibranor Alone and in Combination With SGLT2 Inhibitor EmpaGliflozin in patiEnts With NASH and Type 2 Diabetes Mellituscompletedn=39
• phase3A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heartrecruitingn=4,200
• phase2Empagliflozin in Patients With Cirrhosis and Ascitesrecruitingn=20
• phase3EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)recruitingn=11,000